Is This Dividend Giant Too Rich?

The following video is from Tuesday's MarketFoolery podcast, in which host Chris Hill, along with analysts Jason Moser and Matt Argersinger, discuss the top business and investing stories of the day.

Johnson & Johnson (NYSE: JNJ  ) reported higher than-than-expected earnings. Shares of the consumer giant are up 28% in the past year. Will Johnson & Johnson continue to produce for investors? Should Johnson & Johnson follow Procter & Gamble's (NYSE: PG  ) lead and double down on some of its more profitable assets. In this installment of MarketFoolery, our analysts talk about the future of Johnson & Johnson.

Is bigger really better?
Involved in everything from baby powder to biotech, Johnson & Johnson has its critics convinced that the company is spread way too thin. If you want to know whether J&J is nothing but a bloated corporate whale -- or a well-diversified giant that's perfect for your portfolio -- check out the Fool's new premium report outlining the Johnson & Johnson story in terms that any investor can understand. Claim your copy by clicking here now

The relevant video segment can be found between 10:34 and 17:01.

For the full video of today's MarketFoolery, click here.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2366940, ~/Articles/ArticleHandler.aspx, 4/18/2014 12:08:47 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement